JP2018537076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537076A5 JP2018537076A5 JP2018520493A JP2018520493A JP2018537076A5 JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5 JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- nucleic acid
- isolated nucleic
- catalytic
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 72
- 230000003197 catalytic effect Effects 0.000 claims description 53
- 150000007523 nucleic acids Chemical group 0.000 claims description 53
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 51
- 108020003175 receptors Proteins 0.000 claims description 23
- 102000005962 receptors Human genes 0.000 claims description 23
- 235000018102 proteins Nutrition 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 13
- 230000011664 signaling Effects 0.000 claims description 13
- 125000000539 amino acid group Chemical group 0.000 claims description 9
- 230000003834 intracellular effect Effects 0.000 claims description 9
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 7
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 6
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims description 6
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 6
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims description 4
- -1 ICOS Proteins 0.000 claims description 4
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 4
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 102000006707 alpha-beta T-Cell Antigen Receptors Human genes 0.000 claims description 4
- 108010087408 alpha-beta T-Cell Antigen Receptors Proteins 0.000 claims description 4
- 108010071579 antibody aldolase Proteins 0.000 claims description 4
- 230000000139 costimulatory effect Effects 0.000 claims description 4
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 4
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims description 4
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 108700023418 Amidases Proteins 0.000 claims description 2
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 2
- 102100027207 CD27 antigen Human genes 0.000 claims description 2
- 101150013553 CD40 gene Proteins 0.000 claims description 2
- 102100035793 CD83 antigen Human genes 0.000 claims description 2
- 102100037904 CD9 antigen Human genes 0.000 claims description 2
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 2
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 claims description 2
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims description 2
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 2
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 2
- 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims description 2
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 claims description 2
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims description 2
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 2
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 2
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 2
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 2
- 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 2
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 2
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 2
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 2
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 2
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 2
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 2
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 2
- 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 2
- 108091008874 T cell receptors Proteins 0.000 claims description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 2
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 2
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 2
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 2
- 102000005488 Thioesterase Human genes 0.000 claims description 2
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 2
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 2
- 102000005922 amidase Human genes 0.000 claims description 2
- 102000006635 beta-lactamase Human genes 0.000 claims description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108020002982 thioesterase Proteins 0.000 claims description 2
- 241001529936 Murinae Species 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 description 20
- 239000000427 antigen Substances 0.000 description 14
- 102000036639 antigens Human genes 0.000 description 14
- 108091007433 antigens Proteins 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 210000002865 immune cell Anatomy 0.000 description 11
- 210000000822 natural killer cell Anatomy 0.000 description 11
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 8
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 8
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 8
- 239000013598 vector Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241000700605 Viruses Species 0.000 description 4
- 102000023732 binding proteins Human genes 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 230000008685 targeting Effects 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 2
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 2
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 2
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 2
- 108010008707 Mucin-1 Proteins 0.000 description 2
- 102100034256 Mucin-1 Human genes 0.000 description 2
- RMINQIRDFIBNLE-NNRWGFCXSA-N O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-serine Chemical compound O1[C@H](OC[C@H](N)C(O)=O)[C@H](NC(=O)C)[C@@H](O)[C@@H](O)[C@H]1CO[C@@]1(C(O)=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C1 RMINQIRDFIBNLE-NNRWGFCXSA-N 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108040003607 interleukin-13 receptor activity proteins Proteins 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- 210000000581 natural killer T-cell Anatomy 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 239000000816 peptidomimetic Substances 0.000 description 2
- 229940076376 protein agonist Drugs 0.000 description 2
- 229940076372 protein antagonist Drugs 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- SOAPXKSPJAZNGO-WDSKDSINSA-N (2s)-2-[[(1s)-1,3-dicarboxypropyl]carbamoylamino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)N[C@H](C(O)=O)CCC(O)=O SOAPXKSPJAZNGO-WDSKDSINSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N Folic acid Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 241000713311 Simian immunodeficiency virus Species 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 108700010903 cytomegalovirus proteins Proteins 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 108700010919 epstein-barr-virus proteins Proteins 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 125000003929 folic acid group Chemical group 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 108700010900 influenza virus proteins Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 108700010850 rotavirus proteins Proteins 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245978P | 2015-10-23 | 2015-10-23 | |
| US62/245,978 | 2015-10-23 | ||
| US201662382691P | 2016-09-01 | 2016-09-01 | |
| US62/382,691 | 2016-09-01 | ||
| PCT/US2016/058429 WO2017070654A1 (en) | 2015-10-23 | 2016-10-24 | Programmable universal cell receptors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537076A JP2018537076A (ja) | 2018-12-20 |
| JP2018537076A5 true JP2018537076A5 (enExample) | 2019-09-19 |
Family
ID=58558187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520493A Pending JP2018537076A (ja) | 2015-10-23 | 2016-10-24 | プログラム可能な普遍的細胞受容体およびその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170112878A1 (enExample) |
| EP (1) | EP3365016A4 (enExample) |
| JP (1) | JP2018537076A (enExample) |
| KR (1) | KR20180091820A (enExample) |
| CN (1) | CN108883170A (enExample) |
| AU (1) | AU2016341321A1 (enExample) |
| CA (1) | CA3002774A1 (enExample) |
| EA (1) | EA201890941A1 (enExample) |
| TW (1) | TW201726914A (enExample) |
| UY (1) | UY36961A (enExample) |
| WO (1) | WO2017070654A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016341321A1 (en) * | 2015-10-23 | 2018-06-07 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| WO2017189964A2 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| US11326182B2 (en) | 2016-04-29 | 2022-05-10 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| WO2019010201A1 (en) * | 2017-07-03 | 2019-01-10 | Yale University | REGULATED SMALL MOLECULE ADAPTER |
| KR20200076732A (ko) * | 2017-11-03 | 2020-06-29 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Cd38-지시된 키메라 항원 수용체 작제물 |
| WO2019173837A1 (en) * | 2018-03-09 | 2019-09-12 | Sorrento Therapeutics, Inc. | Dimeric antigen receptors (dar) |
| AU2020369479A1 (en) * | 2019-10-23 | 2022-05-26 | University Of Florida Research Foundation, Incorporated | Novel conjugation chemistry for catalytic antibody 38C2 |
| US20230096410A1 (en) * | 2020-03-06 | 2023-03-30 | Sorrento Therapeutics, Inc. | Innate Immunity Killer Cells Targeting PSMA Positive Tumor Cells |
| EP4225799A4 (en) * | 2020-10-12 | 2024-11-20 | Sorrento Therapeutics, Inc. | CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR CONSTRUCTS |
| EP4274852A4 (en) * | 2021-01-11 | 2025-02-26 | Eutilex Co., Ltd. | BISPECIFIC EPITOP-BINDING PROTEIN WITH ANTI-4-1BB ANTIBODY AND PD-1 PROTEIN OR FRAGMENTS THEREOF AND USE THEREOF |
| CA3215938A1 (en) * | 2021-04-23 | 2022-10-27 | Henry Hongjun Ji | Dimeric antigen receptors (dars) that bind gd2 |
| WO2023154708A2 (en) * | 2022-02-10 | 2023-08-17 | The Scripps Research Institute | Car-t therapies targeted via covalently bonded adapters |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268488B1 (en) * | 1999-05-25 | 2001-07-31 | Barbas, Iii Carlos F. | Prodrug activation using catalytic antibodies |
| AU2004210088A1 (en) * | 2003-02-06 | 2004-08-19 | Micromet Ag | Trimeric polypeptide construct to induce an enduring T cell response |
| CA2696627C (en) * | 2007-08-17 | 2016-09-27 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| EP2483301A1 (en) * | 2009-10-01 | 2012-08-08 | The United States Of America, As Represented By The Secretary, Department of Health and Human Services | Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| EP2593142B8 (en) * | 2010-07-12 | 2018-12-26 | Pfizer Healthcare Ireland | Multifunctional antibody conjugates |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CN107188969B (zh) * | 2011-04-08 | 2021-08-27 | 美国卫生和人力服务部 | 抗-表皮生长因子受体变体iii嵌合抗原受体及其用于治疗癌症的用途 |
| WO2013044225A1 (en) * | 2011-09-22 | 2013-03-28 | The Trustees Of The University Of Pennsylvania | A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens |
| US10851178B2 (en) * | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| AU2016341321A1 (en) * | 2015-10-23 | 2018-06-07 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
-
2016
- 2016-10-24 AU AU2016341321A patent/AU2016341321A1/en not_active Abandoned
- 2016-10-24 KR KR1020187014623A patent/KR20180091820A/ko not_active Withdrawn
- 2016-10-24 CN CN201680076271.2A patent/CN108883170A/zh active Pending
- 2016-10-24 UY UY0001036961A patent/UY36961A/es not_active Application Discontinuation
- 2016-10-24 CA CA3002774A patent/CA3002774A1/en not_active Abandoned
- 2016-10-24 EA EA201890941A patent/EA201890941A1/ru unknown
- 2016-10-24 EP EP16858424.1A patent/EP3365016A4/en not_active Withdrawn
- 2016-10-24 WO PCT/US2016/058429 patent/WO2017070654A1/en not_active Ceased
- 2016-10-24 US US15/333,115 patent/US20170112878A1/en not_active Abandoned
- 2016-10-24 JP JP2018520493A patent/JP2018537076A/ja active Pending
- 2016-10-24 TW TW105134363A patent/TW201726914A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537076A5 (enExample) | ||
| JP7605912B2 (ja) | Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞 | |
| JP7291196B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP6909844B2 (ja) | 細胞 | |
| JP7179030B2 (ja) | Ｒｏｒ１ ｃａｒ ｔ細胞 | |
| JP2022109915A (ja) | Ｃｄ８０バリアント免疫調節タンパク質およびその使用 | |
| JP7313746B2 (ja) | キメラ抗原受容体及び当該キメラ抗原受容体を発現する免疫エフェクター細胞 | |
| KR20200015713A (ko) | 항-trbc1 항원 결합 도메인 | |
| EP3773630A1 (en) | Bcma-car-t cells | |
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| JP7584453B2 (ja) | Ｔａｃｉを標的とする抗体及びキメラ抗原受容体 | |
| CN110461363B (zh) | 靶向cd37的嵌合抗原受体 | |
| US20250236864A1 (en) | CAR LIBRARY AND scFv MANUFACTURING METHOD | |
| JP2020532969A5 (enExample) | ||
| CN116162168A (zh) | 分子开关调控型嵌合抗原受体细胞和抗体的组合及其应用 | |
| CN112442509A (zh) | Cd19-cd20双特异性和双通道car-t及其使用方法 | |
| US20210079111A1 (en) | Cd19-cd20 bispecific and dual passway car-t and methods for use thereof | |
| CN114685659A (zh) | Cd22特异性人源化抗体及利用其的嵌合抗原受体 | |
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 | |
| CN118541394A (zh) | 分泌team的抗间皮素car t细胞及其使用方法 | |
| Angyal et al. | Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases | |
| JPWO2022104424A5 (enExample) |